These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8857956)

  • 1. Endothelial cell surface actin serves as a binding site for plasminogen, tissue plasminogen activator and lipoprotein(a).
    Dudani AK; Ganz PR
    Br J Haematol; 1996 Oct; 95(1):168-78. PubMed ID: 8857956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of tissue plasminogen activator to endothelial cells. The effect on functional properties. Localization of a ligand in the B-chain of tPA.
    Cheng XF; Brohlin M; Pohl G; Bäck O; Wallén P
    Thromb Res; 1995 Jan; 77(2):149-64. PubMed ID: 7740507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of tissue plasminogen activator with a human endothelial cell 45-kilodalton plasminogen receptor.
    Dudani AK; Pluskota A; Ganz PR
    Biochem Cell Biol; 1994; 72(3-4):126-31. PubMed ID: 7818846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of lipoprotein(a) and LDL on plasminogen binding to extracellular matrix and on matrix-dependent plasminogen activation by tissue plasminogen activator.
    Pekelharing HL; Kleinveld HA; Duif PF; Bouma BN; van Rijn HJ
    Thromb Haemost; 1996 Mar; 75(3):497-502. PubMed ID: 8701415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of tissue plasminogen activator to human endothelial cells. Importance of the B-chain as a ligand.
    Cheng XF; Bäck O; Nilsson TK; Nylander Lundqvist E; Pohl G; Wallén P
    Biochem J; 1992 Oct; 287 ( Pt 2)(Pt 2):407-13. PubMed ID: 1332673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethanol-induced up-regulation of the urokinase receptor in cultured human endothelial cells.
    Tabengwa EM; Grenett HE; Benza RL; Abou-Agag LH; Tresnak JK; Wheeler CG; Booyse FM
    Alcohol Clin Exp Res; 2001 Feb; 25(2):163-70. PubMed ID: 11236828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoproteins inhibit the secretion of tissue plasminogen activator from human endothelial cells.
    Levin EG; Miles LA; Fless GM; Scanu AM; Baynham P; Curtiss LK; Plow EF
    Arterioscler Thromb; 1994 Mar; 14(3):438-42. PubMed ID: 8123649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assembly of plasmin-generating proteins on the surface of human endothelial cells.
    Hajjar KA
    Ann Epidemiol; 1992 Jul; 2(4):419-26. PubMed ID: 1342292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue-type plasminogen activator-binding RNA aptamers inhibiting low-density lipoprotein receptor family-mediated internalisation.
    Bjerregaard N; Bøtkjær KA; Helsen N; Andreasen PA; Dupont DM
    Thromb Haemost; 2015 Jul; 114(1):139-49. PubMed ID: 25855589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysine-binding heterogeneity of Lp(a): consequences for fibrin binding and inhibition of plasminogen activation.
    Bas Leerink C; Duif PF; Gimpel JA; Kortlandt W; Bouma BN; van Rijn HJ
    Thromb Haemost; 1992 Aug; 68(2):185-8. PubMed ID: 1412165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue-type plasminogen activator binds to and is inhibited by surface-bound lipoprotein(a) and low-density lipoprotein.
    Simon DI; Fless GM; Scanu AM; Loscalzo J
    Biochemistry; 1991 Jul; 30(27):6671-7. PubMed ID: 1829635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of Lp(a) with plasminogen binding sites on cells.
    Miles LA; Fless GM; Scanu AM; Baynham P; Sebald MT; Skocir P; Curtiss LK; Levin EG; Hoover-Plow JL; Plow EF
    Thromb Haemost; 1995 Mar; 73(3):458-65. PubMed ID: 7667829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis.
    Caplice NM; Panetta C; Peterson TE; Kleppe LS; Mueske CS; Kostner GM; Broze GJ; Simari RD
    Blood; 2001 Nov; 98(10):2980-7. PubMed ID: 11698280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein(a): a kinetic study of its influence on fibrin-dependent plasminogen activation by prourokinase or tissue plasminogen activator.
    Liu JN; Harpel PC; Pannell R; Gurewich V
    Biochemistry; 1993 Sep; 32(37):9694-700. PubMed ID: 8373773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein(a), fibrin binding, and plasminogen activation.
    Loscalzo J; Weinfeld M; Fless GM; Scanu AM
    Arteriosclerosis; 1990; 10(2):240-5. PubMed ID: 2138452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of tissue plasminogen activator to cultured human endothelial cells.
    Hajjar KA; Hamel NM; Harpel PC; Nachman RL
    J Clin Invest; 1987 Dec; 80(6):1712-9. PubMed ID: 3119664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of fibrinolysis by lipoprotein(a).
    Anglés-Cano E; de la Peña Díaz A; Loyau S
    Ann N Y Acad Sci; 2001; 936():261-75. PubMed ID: 11460483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defensin modulates tissue-type plasminogen activator and plasminogen binding to fibrin and endothelial cells.
    Higazi AA; Ganz T; Kariko K; Cines DB
    J Biol Chem; 1996 Jul; 271(30):17650-5. PubMed ID: 8663495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of O2*-/HO* free radical- and copper ions-oxidized LDL or lipoprotein(a) on the endothelial cell releases of tissue plasminogen activator and plasminogen activator inhibitor-1.
    Beaudeux JL; Therond P; Bonnefont-Rousselot D; Gardes-Albert M; Legrand A; Delattre J; Peynet J
    Life Sci; 2001 Oct; 69(20):2371-82. PubMed ID: 11681624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiostatin and plasminogen share binding to endothelial cell surface actin.
    Dudani AK; Ben-Tchavtchavadze M; Porter S; Tackaberry E
    Biochem Cell Biol; 2005 Feb; 83(1):28-35. PubMed ID: 15746964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.